Market Updates

Each week we’ll post a roundup of the news and announcements from the pharma industry including EC & FDA Drug Approvals, updates on biosimilars and further industry reading, to keep you up-to-date on all the activity from the week!   

This Week

Sláintecare Action Plan – 2019

Sláintecare article in Sunday Business Post – 17th March, 2019.

March 2019

Prof Michael Barry article – Sunday Business Post, March 3rd

 

February 2019

Version 36 – 22nd February 

Companies Mentioned: Abbott, AbbVie, AstraZeneca, Bayer, Eli Lilly, IQVIA, MSD, Mylan, Novo Nordisk, Pfizer, Roche, Takeda

Version 34 – 8th February

Companies Mentioned: Astellas, AstraZeneca, BMS, Celgene, GSK, Merck Group, MSD, Novartis, Perrigo, Pfizer, Roche and Vertex 

January 2019

Version 33 – 25th January, 2019

Companies mentioned: Amgen,  Astellas, GSK, MSD,  Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and Vertex

Version 32 – 18th January, 2019

Companies mentioned: AbbottAmgen, Clonmel Healthcare, GSK, Merck, MSD, Mundipharma, Novartis, Pfizer, Roche, Shire, Takeda and UCB Pharma

Version 31 – 11th January 2019

Companies mentioned: Amgen, Mylan, Novartis, Pfizer, Sanofi, Shire, Takeda and Teva

Version 30 – 4th January 2019 

Companies mentioned: Amgen, Boston Scientific, Bristol-Myers Squibb,  Merck, Novartis, Pfizer and Teva

December 2018 

Version 29 – 21st December, 2018

Companies mentioned: Amgen, GSK, Pfizer, MSD, Novartis, RecordatiRoche, Sanofi, Shire,Tesaro & Vertex 

Versions 28 – 14th December, 2018 

Companies Mentioned: Amgen, AstraZeneca, Genentech, Gilead, GSK, J&J, MSD, Novartis, Nuritas, Pfizer,  Roche, Shire and Takeda

November 2018

Version 27 – w/e 30th November, 2018 

Companies mentioned: AbbVie, Amgen, Astellas, Bayer, HealthBeacon, MSD, Mundipharma, Novo Nordisk, Novartis, Pfizer, Roche, Vertex

Version 26 – w/e 23rd November, 2018

Companies mentioned: Boston Scientific, Eli Lilly, GSK, hmR International, Janssen, MSD, Novartis, Pfizer, Recordati, Sanofi, Shire and Takeda

Version 25 – w/e 16th November, 2018

Companies mentioned: AmgenAstraZeneca, Bristol-Meyers Squibb, GSK, JanssenMerck SeronoMSD, Novartis, Pfizer, Samsung Pharmaceutical, Shire, Takeda and Vertex

Version 24 – w/e 9th November, 2018

Companies mentioned: Amgen, Astellas, AstraZeneca, GSK, Hitachi, Jazz Pharmaceuticals, Merck Group, MSD, Pfizer, Novartis, Roche, and Uniphar

Further reading: 
Bruised, battered, but unbowed. Tony O’Brien’s interview with Susan Mitchell, Sunday Business Post

October 2018

 


Version 23 – w/e 26th October, 2018 

Companies mentioned: Amgen, AstraZeneca, Eli Lilly, Lundbeck, MSD, Novartis, Pfizer, Shire, Takeda

Further reading: 

  • A possible “Humirageddon:” Perspectives on the EU biosimilar launch
  • Agility: How Pharma Can Be Bolder, Faster, Better Whitepaper from eyeforpharma

 

Version 22 – w/e 19th October

Companies mentioned: AbbVie, Amgen, AstraZeneca,  Eli Lilly, Gilead, GSK, Grünenthal, MSD Ireland, MSD,  Novartis, Pfizer, Roche, Samsung Bioepis , Shire and ViiV Healthcare

Further reading: 

• Tufts study uncovers the economic advantage of single-source drug development and manufacturing
• Fighting the Opioid epidemic: How Grünenthal’s abuse-deterrent technology contributes

Version 21 – w/e 12th October

Companies mentioned:  AmgenBayerBiogenGilead SciencesGSKMSD, Mundipharma, MylanNovartisPfizer, and Roche

Version 20 – w/e 5th October

Companies mentioned: Amgen, Astellas, Eli Lilly, GSK, Janssen, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi, and Takeda 

PMI Avatar

September 2018

Version 19 – w/e 28th September. 

Companies mentioned: Amgen, Astellas, AstraZeneca, Biogen, CSL Behring, Eli Lilly, Ferring, GSK, Novartis, Pfizer, Roche, Sandoz, Shire and Takeda 

Version 18 – w/e 21st September 

Companies mentioned:  Abbott, AstraZeneca,  Bayer, Bristol-Meyers Squibb,  GSK,  Janssen, MSD,  Mylan, Novartis, Pfizer, Shire, Takeda and Teva 

  • Further reading: 
    • New HSE Chairman announced
    • Overview of Diabetes Therapeutics Market 

Version 17 – w/e 14th September

Companies mentioned: Amgen, AstraZeneca, Astellas, Bristol-Meyers Squibb,  GSK,  Janssen, MSD, Mylan, Novartis, Otsuka Pharmaceutical, Pfizer, Shire and Takeda

Further Reading: 

  • PARADIGMS study published
  • India bans 328 combination drugs
  • Five drugs manufactured in Ireland for the treatment of cancer and heart disease are not sanctioned for use here
  • Novartis survey shows psoriasis patients want treatment effect beyond clear skin

Week 16 – 7th September 2018 

Companies Mentioned: AstraZeneca, Bristol-Meyers Squibb, Celltrion Healthcare,  Chanelle, GSK,  Janssen, JW Pharmaceutical , Leo Pharma, MSD, Novartis, Pfizer, Sandoz, Sanofi and Shire
Further Reading: 

August 2018

Week 15 – 30th August 2018

Companies mentioned: Amgen, Bayer, Gilead, GSK, Jazz Pharmaceuticals, Johnson & Johnson, Leo Pharma, MSD, Novartis, Pfizer, Roche & Shire

Further reading: 

  • Sláintecare 
  • Brexit articles
  • Big pharma takes a gamble on NHS experiment

Week 14 – 24th August 2018. 

Companies mentioned: Amgen, Astellas, AstraZeneca,  Biontech, Eisai, GSK, MSD,  Pfizer,  Shire, Teva,and Uniphar Group 

Further reading: 

  • Direct-to-consumer genetic testing
  • Sláintecare 
  • Machine Learning in drug discovery & patient diagnosis 
  • UK Government set of guidelines re no-deal Brexit 

Version 13 – Week Ending 17th August

Companies mentioned: Amgen, Astellas, AstraZeneca, Biogen, Bristol-Meyer-Squibb, GSK, Janssen, MSD, Mylan, Novartis, Novo Nordisk, PamEx, Pfizer, Regeneron, Roche, Teva, 

Further reading: 

  • Report: pharma companies’ reputation among mental health patient groups
  • Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L
  • Article: Potential in oral delivery of biologics 
  • Blood marker that could predict the risk of developing kidney cancer

Version 12 – Week Ending 10th August 
Companies mentioned:  Merck, MSD Ireland, Mylan, Novartis, Perrigo, Pfizer and Sanofi

Version 11 – Week Ending 3rd August.

Companies mentioned: Aegerion Pharmaceuticals, Beats Medical, Leo Pharma, MSD, Novartis, Pfizer and Shire 

PMI Avatar

July 2018

Version 10 – Week Ending 13th July
Companies mentioned: Bristol Myers-Squibbs, GSK, MSD, Mylan, Novartis, Pfizer, Shire and Takeda  

Version 9 – Week Ending 6th July
Companies mentioned: Amgen, Ferring, GSK, PHA, MSD, Novartis, Pfizer, Sanofi and Shire. 

PMI Avatar

June 2018

Version 8 – Week Ending 29th June 
Companies mentioned: Amgen, AstraZenecaGilead, GSK, MSD, Novartis, Pfizer, Roche and Shire

Version 7 – Week Ending 22nd June 
Companies mentioned: Amgen, Gilead, GSK, Janssen MSD, MylanNovartis, Novo Nordisk, Pfizer and Shire

Version 6 – Week Ending 15th June
Companies mentioned: AmgenAstellas, AstraZeneca, BioMarinGSK, MSDMylan, NovartisPfizer, SanofiServierShire and Takeda

Version 5 – Week Ending 6th June,
Companies mentioned: Astellas, GSK, Mylan, NovartisPfizer, Sanofi, Shire and Takeda

PMI Avatar

May 2018

Version 4 – 25th May